Pfizer & Mylan: $ Trumps Life! #BusinessEthics #Morality
Pfizer and Mylan will use the classic automobile tactic for handling defects. It costs less to be sued and settle than the cost of resulting from recalls.
EpiPen customers should read “How to Get the Best Deal on EpiPen and Alternatives” from Consumer Reports
And let’s not forget that on Aug. 17, 2017, “EpiPen Maker to Finally Pay $465 Million for Ripping Off Taxpayers”
The manufacturer of EpiPen devices failed to address known malfunctions in its epinephrine auto-injectors even as hundreds of customer complaints rolled in and failures were linked to deaths, according to the Food and Drug Administration.
The damning allegations came to light today when the FDA posted a warning letter it sent September 5 to the manufacturer, Meridian Medical Technologies, Inc. The company (which is owned by Pfizer) produces EpiPens for Mylan, which owns the devices and is notorious for dramatically raising prices by more than 400 percent in recent years.
In the letter, the agency wrote:
“In fact, your own data show that you received hundreds of complaints that your EpiPen products failed to operate during life-threatening emergencies, including some situations in which patients subsequently died.”
“Nonetheless, on June 3, 2016, you concluded that the defect was infrequent, even though you had not examined all of your reserve samples to determine the extent of the defect within the same lot of finished products, nor did you expand your investigation to other lots...
You closed your investigation and determined that “no market action would be taken.”